Electrical Stimulation Devices Market Size, Share and Global Trend By Device Type (Transcutaneous Electrical Nerve Stimulation, Interferential Current Electrical Stimulation, Electrical Muscle Stimulation, Russian Stimulation), By Application (Orthopedic Disorders, Muscle Weakness or Paralysis), By End User (Hospitals, Speciality Clinics, Ambulatory Surgery Centers, Others), and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Electrical stimulation or neuromuscular electrical stimulation (NMES) is a technique used to trigger muscle contraction with the help of electrical impulses. Electrodes are usually placed on the skin that generates the electrical impulses. They help in reducing acute post-operative pain and swelling, maintaining muscle tone, treating chronic intractable pain, during temporary extremity immobilization, reducing spasticity, and assisting spinal cord injured patients to grasp, stand, and helps in walking independently.
Transcutaneous electrical nerve stimulation, interferential current electrical stimulation, electrical muscle stimulation, Russian stimulation, neuromuscular electrical stimulation, functional electrical stimulation is some of the widely used electrical stimulators. Increasing prevalence of muscle disorders and growing demand for effective technology are likely to boost the electrical stimulation devices market during the forecast period.
To gain extensive insights into the market, Request for Customization
The growth in the electrical stimulation device market is being driven by an increase in the demand for the novel devices in the treatment of muscle contradictions, growing research and development activities and increasing adoption of emerging electrical stimulation devices.
However, the growing cost of treatment unaffordable by middle-low income countries are likely to hamper the growth of electrical stimulation device market during the forecast period.
Key Players Covered
Some of the major companies that are present in the electrical stimulation market are MYOLYN, OMRON Corporation, Zynex Medical, NeuroMetrix, Inc., DJO, RS Medical, NeuroMetrix, Inc., Cogentix Medical., Zynex Medicala among others.
SEGMENTATION
SEGMENTATION | DETAILS |
By Device Type | · Transcutaneous Electrical Nerve Stimulation (TENS) · Interferential Current Electrical Stimulation (IFC) · Electrical Muscle Stimulation (EMS) · Russian Stimulation · Neuromuscular Electrical Stimulation (NMES) · Functional Electrical Stimulation (FES) · Others |
By Application | · Orthopedic Disorders · Muscle Weakness or Paralysis · Stroke and Traumatic Brain Injury · Spinal Cord Injury · Others |
By End User | · Hospitals · Speciality Clinics · Ambulatory Surgery Centers · Others |
By Geography | · North America (the U.S. and Canada) · Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) · Latin America (Brazil, Mexico, and Rest of Latin America) · Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa) |
Among end users, hospital segments are likely to hold the largest market share during the projected period owing to the increase in the hospitalization of patients with muscle weakness or spinal cord injuries and growing inpatient and outpatient care provided by hospitals.
Key Insights
- Overview of Technological Advances in Electrical Stimulation Devices
- Overview of Incidences of Spinal Cord Injuries
- The Regulatory Scenario for Key Countries/Regions
- Key Industry Developments- Mergers, Acquisitions, and Partnerships
Regional Analysis
Geographically, the global electrical stimulation device market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global electrical stimulation device market during the projected period owing to the growing prevalence of spinal cord injury and growing awareness about new devices used for the treatment and growing investments in healthcare domain by government authorities. The increase in the patient population and demand for the effective therapies in the treatment of muscle weakness and spinal cord injury are some the factors likely to fuel the growth in electrical stimulation device market in Asia Pacific region during the forecast period.
Key Industry Developments
- In March 2019, CARMEL, Ind., received FDA market clearance for the Cervella Cranial Electrotherapy Stimulator. The FDA cleared the Cervella medical device for treatment of anxiety, depression, and insomnia.
- In April 20218, Cala Health received FDA Clearance for Cala ONE as an individualized prescription neuromodulation therapy for transient relief of hand tremors in adults with essential tremor (ET)
- Ongoing
- 2023
- 2019-2022
Personalize this Research
- Granular Research on Specified Regions or Segments
- Companies Profiled based on User Requirement
- Broader Insights Pertaining to a Specific Segment or Region
- Breaking Down Competitive Landscape as per Your Requirement
- Other Specific Requirement on Customization
Healthcare Clients
